As of this writing, the geneticists are still determining the genetics of hEDS and hypermobility to thereby develop a cure. Here is what is known. Myth: EDS/HSD is not treatable. Fact: EDS/HSD is indeed treatable. Myth: Pain in EDS/HSD is due to fibromyalgia. Fact: Pain in EDS/HSD is not due to fibromyalgia. (fibromyalgia is a strictly defined rheumatological disorder that does not include EDS/HSD.) EDS/HSD is primarily inflammatory and is due to defective connective tissue, joint mobility, and P&S dysfunction. Myth: Primary anxiety causes most EDS/HSD symptoms. Fact: P&S dysfunction causes most EDS/HSD symptoms, including amplified pain. Myth: hEDS is benign and should not be aggressively addressed. Fact: While hEDS has a normal life expectancy, its morbidity makes it not a benign disorder. Myth: POTS and other dysautonomias cannot be aggressively treated. Fact: False! P&S dysfunctions are treatable. Myth: Genetic testing is necessary for hEDS. Fact: False! Genetic testing is negative in hEDS. Genetic testing should be ordered for those suspected of vEDS or kEDS, or an alternate hereditary connective tissue disorder. Myth: vEDS is invariably fatal and always decreases life expectancy. Fact: False! Close surveillance, proper pharmacological and lifestyle therapies, and attention to any early warning symptoms extend vEDS patients’ life expectancy.